Skip to main content

Vanguard Group Inc

SEC CIK
0000102909
Latest filing
Jan 29, 2026

BNTC holding history

Benitec Biopharma Inc. in every 13F filed by Vanguard Group Inc, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

BNTC overviewAll 13F holders of BNTCFull Q4 2025 holdings

Shares (Q4 2025)
1,174,758
Value
$15.8M
% of portfolio
<0.1%
Quarters held
19
Since Q1 2021
Holdings of BNTC by Vanguard Group Inc, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q4 20251,174,758$15.8M<0.1%+182,644+18.4%AddedHolders
Q3 2025992,114$13.9M<0.1%+22,948+2.4%AddedHolders
Q2 2025969,166$11.3M<0.1%+642,132+196.4%AddedHolders
Q1 2025327,034$4.25M<0.1%+27,013+9.0%AddedHolders
Q4 2024300,021$3.79M<0.1%+86,954+40.8%AddedHolders
Q3 2024213,067$1.96M<0.1%−2,003−0.9%ReducedHolders
Q2 2024215,070$1.50M<0.1%+198,369+1,187.8%AddedHolders
Q1 202416,701$87.7K<0.1%00.0%UnchangedHolders
Q4 202316,701$53.9K<0.1%+16,701NewHolders
Q3 20230$00.0%−4,398−100.0%Sold outConverted for a 1-for-17 splitHolders
Q2 202374,773$17.8K<0.1%00.0%UnchangedHolders
Q1 202374,773$15.7K<0.1%00.0%UnchangedHolders
Q4 202274,773$12.7K<0.1%00.0%UnchangedHolders
Q3 202274,773$28.0K<0.1%−3,598−4.6%ReducedHolders
Q2 202278,371$91.0K<0.1%00.0%UnchangedHolders
Q1 202278,371$183.0K<0.1%00.0%UnchangedHolders
Q4 202178,371$205.0K<0.1%00.0%UnchangedHolders
Q3 202178,371$280.0K<0.1%+3,598+4.8%AddedHolders
Q2 202174,773$318.0K<0.1%+22,579+43.3%AddedHolders
Q1 202152,194$270.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.